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(Abnormal blood pressure response to exercise is reported to
ccur in up to a third of hypertrophic cardiomyopathy (HCM) cases
nd is associated with an increased risk of death, particularly in
he young, but it is not known whether the HCM-causing mutation
nfluences blood pressure response to exercise. The purpose of this
rticle is to ascertain whether the blood pressure response to
xercise differs among carriers of the R92W mutation in the car-
iac troponin T gene (TNNT2), which has been associated with an
ncreased risk of sudden cardiac death in young males; carriers of
utations in the cardiac -myosin heavy chain gene (MYH7); and
heir noncarrier relatives. Thirty R92WTNNT2 carriers, 51 MYH7 mu-
ation carriers, and 68 of their noncarrier relatives were subjected
o bicycle ergonometric exercise testing to assess blood pressure
esponse to, as well as heart rate recovery after, exercise. Addi-
ional echocardiographic and demographic details were docu-
ented for all participants. R92WTNNT2 carriers demonstrated sig-
ificantly more abnormal blood pressure responses to exercise
P  .021; odds ratio 3.03; confidence interval 1.13–8.12) and
maller increases in systolic blood pressure than MYH7 mutationr
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i505, South Africa. E-mail address: HM@sun.ac.za.
547-5271/$ -see front matter © 2009 Heart Rhythm Society. All rights reservedormal blood pressure response occurred at similar frequencies
n males in all groups (23%–26%), the percentage of R92WTNNT2
emales with abnormal blood pressure response was 64%, com-
ared with 25% for MYH7 and 22% for noncarriers. Therefore,
hese results show that blood pressure response to exercise is
nfluenced by genotype and gender in patients with HCM.
EYWORDS Hypertrophic cardiomyopathy; Abnormal blood pres-
ure response; Survival; Troponin T; Beta-myosin; Genetic muta-
ion
BBREVIATIONS Ca2  calcium; CR  chronotropic response;
BP  diastolic blood pressure; ECG  electrocardiogram;
CM  hypertrophic cardiomyopathy; HR  heart rate; LV  left
entricle; LVM  left ventricular mass; maxLVWT  maximum left
entricular wall thickness; METs  metabolic equivalents;
YH7  beta cardiac myosin heavy chain gene; SBP  systolic
lood pressure; SCD  sudden cardiac death; TNNT2  cardiac tro-
onin T gene
Heart Rhythm 2009;6:S18–S24) © 2009 Heart Rhythm Society. All
arriers or related noncarrier control individuals. Although ab- rights reserved.ntroduction
ypertrophic cardiomyopathy (HCM), a primary cardiac
uscle disease with 0.2% prevalence,1 is characterized pri-
arily by thickening of the ventricular wall in the absence
f other hypertrophy-predisposing conditions1 and by an
ncreased risk for sudden cardiac death (SCD), which may
The first two authors contributed equally to this work. This study was
unded by a Wellcome Trust International Senior Research Fellowship. The
ivid 7 cardiovascular ultrasound system was provided pro bono by GE
ealthcare (Germany) for the duration of the study. None of the authors
ave any conflict of interest to disclose. Address reprint requests and
orrespondence: J. C. Moolman-Smook, MRC/US Centre for Molecular
nd Cellular Biology, Room 4036, University of Stellenbosch Health
ciences Faculty, Francie van Zijl Street, P.O. Box 19063, Tygerbergelate to changes in cardiac energy and/or Ca2 homeostasis
r histopathological changes in the myocardium.2 HCM is
ypically caused by mutations in genes encoding protein
omponents of the cardiac sarcomere (http://genetics.med.
arvard.edu/seidman/cg3/index.html), with the three most
ommon causes being mutations in the genes encoding beta
ardiac myosin heavy chain (MYH7), cardiac troponin T
TNNT2), and myosin binding protein C. Although the phe-
otypes resulting from these genetic defects vary greatly, mu-
ations in TNNT2 in humans3,4 and in animal models5,6 have
requently resulted in an increased susceptibility to SCD,
ften in the presence of mild or absent cardiac hypertrophy.
e have previously reported an increased frequency of
CD, affecting young males in particular, in HCM families
n which the R92W mutation in TNNT2 segregates,7 al-
. doi:10.1016/j.hrthm.2009.07.020
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S19Heradien et al Blood Pressure Response to Exercisehough the reason for this poor prognosis was not investi-
ated at the time.
Blood pressure response to exercise testing is commonly
sed as an indicator of risk for SCD in patients with HCM.
he failure of blood pressure to increase appropriately in
esponse to exercise has been recorded in 8%–33% of
ngenotyped patients with HCM.8–10 Abnormal blood pres-
ure responses have been associated with an increase in
ardiovascular mortality8,11 and have a reported 15% posi-
ive predictive value for SCD in HCM.11 It is not known
hether the blood pressure response to exercise in HCM is
nfluenced by genotype.
We hypothesized that the R92W mutation, which confers
high rate of SCD, may be associated with an abnormal
lood pressure response to exercise. Here we investigated
his hypothesis by comparing the blood pressure response to
xercise in carriers of the R92WTNNT2 mutation with that of
arriers of HCM-causing mutations in the cardiac -MYH7
utations (A797T and R403W) and noncarrier relatives.12
ethods
ubjects
he study was approved by the Institutional Review Board
f the University of Stellenbosch Health Sciences Faculty
N04/03/062). Individuals belonging to consecutively identi-
ed HCM families in which either of three founder HCM-
ausing mutations segregate (R92WTNNT2, A797TMYH7,
403WMYH7)13 who did not have pacemakers, who were in
inus rhythm at the time of the exercise test, and who gave
ritten informed consent were included in this study.
A medical and family history was taken, and age, sex,
eight, and weight as well as sudden death events that had
ccurred in family members were recorded for each partic-
pant. Only sudden deaths occurring in genotyped mutation
arriers, or obligate heterozygotes, or individuals with a
iagnosis of HCM, or with a history of syncope were con-
idered as SCDs. Blood pressure was taken twice in the
itting position, after 5 minutes of bed rest, and the second
easurement was used. Individuals were coded as hyper-
ensive if they on more than one occasion had systolic blood
ressure (SBP) 140 mmHg or diastolic blood pressure
DBP) 90 or were on antihypertensive medication.
xercise testing
e performed 12-lead electrocardiography (ECG) on a
AC 1200ST machine after 5 minutes of rest in the supine
osition and from this determined a resting heart rate (HR)
nd whether normal sinus rhythm was present. All cardio-
ctive medications were discontinued for at least 5 pharma-
okinetic half-lives before exercise testing. Exercise testing
as performed by practitioners who were blinded to the
enotype status of the participants.
Maximum symptom-limited bicycle ergonometric exer-
ise testing was performed according to the following pro-
ocol: eight stages over 24 minutes with incremental in-
rease of 25 W every 2 minutes (25–200 W). Concurrent
ontinuous 12-lead ECG monitoring was performed with whe Norav Medical System. SBP and DBP were recorded
ith a mercury sphygmomanometer by a trained nurse
AG). Blood pressure values were recorded at rest, at
-minute intervals during exercise, and at 1-minute intervals
or 5 minutes during the recovery period.
We recorded the maximal workload achieved (in meta-
olic equivalents [METs]), total exercise time (in minutes
nd seconds), the maximum SBP and DBP achieved during
xercise, the SBP and DBP and HR at peak exercise and at
-minute intervals during recovery, and the percentage of
redicted maximal HR for age and sex achieved by peak
xercise. The predicted maximal HR was calculated as 220
inus age for men and 210 minus age for women.14 Chro-
otropic reserve (CR) was calculated as described else-
here.15
Normal blood pressure response was defined as an in-
rease of at least 20 mmHg in SBP during exercise, with a
radual decline during recovery.11 Abnormal blood pressure
esponses were defined as either (1) an initial increase in
BP with a subsequent fall of 20 mmHg compared with
he blood pressure value at peak exercise or a continuous
ecrease in SBP throughout the exercise test of 20 mmHg
ompared with resting blood pressure (termed hypotensive
esponses) or (2) an increase of 20 mmHg in SBP from
esting state to peak exercise (termed a flat response).
Exercise was terminated for any of the following reasons:
eaching target HR, fatigue, severe dyspnea, significant chest
ain, near syncope, or development of arrhythmias.
chocardiography
chocardiography was performed on all participating individ-
als, using a standardized procedure, by a single experienced
chocardiographer (MR) who was blinded to mutation sta-
us. A GE Healthcare Vivid7 cardiovascular ultrasound sys-
em was used to determine maximum wall thickness at 16
eft ventricular (LV) wall segments on M-mode and two-
imensional images, as described elsewhere.13 Overall
aximum LV wall thickness (maxLVWT) was recorded for
ach individual.
LV mass (LVM) was calculated using the American
ociety of Echocardiography formula for estimation of
VM from two-dimensional LV linear dimensions as de-
cribed elsewhere.13 Ejection fraction was determined by
he biplane method of discs, using the modified Simpson’s
ule, while fractional shortening was calculated using LV
iastolic and systolic diameters from two-dimensional echo-
ardiography images.16 Stroke volume was calculated as
V  7⁄2.4  LVd  LVd3  7⁄2.4  LVs
 LVs3,
here LVd  LV end-diastolic diameter and LVs  LV
nd-systolic diameter. Cardiac output was calculated as
O  (SV  HR)/100, where SV is stroke volume and
R is resting HR.
LV outflow obstruction was considered to be present
hen a peak instantaneous subaortic gradient 30 mmHg
as estimated with continuous wave Doppler echocardiog-
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S20 Heart Rhythm, Vol 6, No 11S, November Supplement 2009aphy under resting conditions.17 Mitral regurgitation was
raded semiquantitatively (1–4 scale).18
tatistical analyses
omparisons were made among three groups consisting of
oncarriers, carriers of the R92WTNNT2, and carriers of
ither of the MYH7 mutations. Quantitative variables were
uantile normalized before modeling.19 As the distribution
f age, gender, body size, and resting hemodynamic param-
ters varied between groups, these factors were adjusted for
n statistical comparisons of the hemodynamic responses
uring exercise between groups. General (quantitative) and
eneralized (dichotomous, categorical) linear mixed-effects
odels were used, as required, with adjustment for family
elatedness as random factor (R package). P .05 was
onsidered statistically significant.
esults
hirty R92WTNNT2 carriers from seven families, 51 MYH7
utation carriers (27 A797TMYH7 carriers from 10 families,
4 R403WMYH7 carriers from three families) and 68 of their
oncarrier relatives participated in exercise testing. The
elevant clinical and demographic characteristics of these
ndividuals are given in Table 1. Total exercise time, work-
oad, and percentage of target HR achieved were similar
etween groups (Table 2). In the R92WTNNT2 families, SCD
ad affected predominantly young males (eight males, age
t SCD 22.5  10 years [mean  standard deviation]; one
emale, 62 years; Table 3). Among MYH7 mutation carriers,
able 1 Clinical characteristics of subjects
MYH7
51
ales, % (n) 35 (69
ge, years 38 (17
ody surface area, kg/m2 1.9 (1.3
VM, g 182 (71
axLVWT, mm 13.8 (7.7
eft atrial diameter, mm 35.8 (20
V end-diastolic diameter, mm 44.0 (32
V end-systolic diameter, mm 26.8 (17
jection fraction, % 70 (57
V, mL 83 (33
ardiac output at rest 6.2 (2.0
esting HR, bpm 75 (60
BPresting, mmHg 120 (80
BPresting, mmHg 80 (60
utflow tract gradient 30 mmHg 0 (0)
ystolic anterior motion of the mitral valve 4 (8)
R  1 18 (36
R  2 1 (2)
YHA 2 8 (16
trial fibrillation 2 (4)
ypertension diagnosis 7 (14
axLVWT 30 mm 4 (8)
yncope 4 (8)
Families with SCD 39
Note: Values are given as median (range) for continuous variables and a
ork Heart Association (NYHA) class 2 or mitral regurgitation (MR) score 2 (accove male (mean age at SCD 35.8  17.3 years) and three
emale (mean age at SCD 32  20.2 years) A797TMYH7
arriers experienced SCD before the study. At least five of
he MYH7 and all R92WTNNT2 SCDs had occurred during
eriods of physical activity or emotional excitement (Table
). One SCD in each of the R92WTNNT2 and MYH7 groups
ccurred in females 40 years.
Whereas abnormal blood pressure response to exercise
ccurred in about a quarter of control individuals or indi-
iduals carrying either MYH7 mutation, this phenomenon
as present in significantly more, that is, nearly half, of
92WTNNT2 carriers (Table 2). No individuals demonstrated
continuous decrease in SBP throughout the exercise test.
lat abnormal blood pressure responses predominated in all
roups but were the only type of abnormal blood pressure
esponse in R92WTNNT2 carriers (Table 2). Statistical anal-
sis indicated that R92WTNNT2 carriers were 3 times as
ikely to demonstrate an abnormal blood pressure response
o exercise compared with either MYH7 mutation carriers or
oncarrier control individuals (Table 4). This was particu-
arly noticeable for female R92WTNNT2 carriers (Figure 1);
he percentage of females with abnormal blood pressure
esponse for R92WTNNT2 was 64%, for MYH7 25%, and for
oncarriers 22%. In contrast, the percentage of males with
bnormal blood pressure response was similar for the three
roups (R92WTNNT2 24%; MYH7 23%; noncarriers 26%).
After adjustment for age, sex, resting mean arterial pres-
ure, and resting HR, the effect of exercise on HR and DBP
arameters (Table 2) was not different between groups.
R92WTNNT2 Controls
30 68
12 (41) 31 (46)
34 (14–66) 34 (17–63)
1.7 (1.3–2.1) 1.8 (1.3–2.3)
126 (48–290) 122 (58–272)
) 11.6 (6.7–30.0) 10.1 (7.1–27.0)
0) 32.9 (21.0–49.0) 30.6 (22.0–45.0)
0) 40.5 (33.0–48.0) 44.0 (37.0–60.0)
0) 22.7 (16.1–33.2) 28.0 (21.0–44.0)
71 (61–79) 65 (52–75)
78 (43–103) 80 (48–133)
) 5.3 (3.3–8.9) 6.0 (4.2–10.9)
72 (55–118) 78 (48–123)
110 (90–130) 115 (90–160)
70 (60–90) 80 (60–100)
0 (0) 0 (0)
0 (0) 0 (0)
4 (15) 4 (7)
1 (4) 1 (2)
3 (11) 2 (3)
2 (7) 0 (0)
0 (0) 2 (3)
1 (3) 0 (0)
3 (10) 2 (3)
57 NA
ers (percentage) for categorical variables. No individuals were above New)
–72)
–2.5)
–477)
–38.2
.0–65.
.0–52.
.0–38.
–81)
–124)
–11.3
–145)
–140)
–100)
)
)
)
s numb
rding to Zhogbi et al.33 2003). NA  not applicable.
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S21Heradien et al Blood Pressure Response to Exerciseowever, R92WTNNT2 carriers achieved a significantly
ower mean SBP at peak exercise, as well as a smaller mean
hange (Table 2) and a smaller percentage of change in SBP
Figure 2) between resting and peak exercise, than did
oncarriers and MYH7 mutation carriers.
Interestingly, we also observed that, while the mean rate
f SBP change increased in the first 3 minutes of exercise in
he control and MYH7 groups, R92WTNNT2 carriers on av-
rage demonstrated a slight decrease in the rate at which
BP changed during the first 3 minutes of exercise (Figure
). However, perhaps owing to the small numbers of indi-
iduals involved, this difference was not statistically signif-
cant.
iscussion
bnormal blood pressure response to exercise has been
ssociated with HCM-related death, with patients 50
able 2 Blood pressure and HR response to exercise in R92WTN
MYH7
otal exercise time, seconds 528 (96–110
ET, kcal/min 6.5 (2.3–12.
HR achieved 96 (74–104
CR 88.0 (32.3–14
Rpeak, bpm 171 (129–20
HR, bpm 92.0 (10–140
bnormal blood pressure response, any (%) 12 (24)
lat (%) 10 (20)
ypotensive (%) 2 (4)
BPpeak, mmHg 160 (120–23
SBP, mmHg 35 (0–100)
BPpeak, mmHg 90 (70–120
DBP, mmHg 10 (	20–40
Note: Values are given as median (range) for continuous variables an
etween groups for quantile normalized data, adjusted for age, sex, resting
nd peak exercise; peak  parameter at peak exercise; % HR achieved 
able 3 Characteristics of individuals who experienced SCD
amilies Sex Age, years Circumstances of SCD
92WTNNT2:
Ped 100 F 62 Physical exertion
Ped 100 M 16 Physical exertion
Ped 100 M 14 Physical exertion
Ped 100 M 36 Physical exertion
Ped 109 M 23 Physical exertion
Ped 137 M 17 Physical exertion
Ped 137 M 15 Physical exertion
Ped 139 M 40 Physical exertion
Ped 139 M 19 Physical exertion
797TMYH7:
Ped 101 F 55 Washing dishes
Ped 101 F 24 Upon return from work
Ped 101 F 17 Emotional exertion
Ped 101 M 22 Physical exertion
Ped 104 M 40 Physical exertion
Ped 131 M 23 Sedentary
Ped 147 M 30 Physical exertion
Ped 158 M 64 Physical exertionNote: F  female; M  male.ears old showing a fourfold increase in premature HCM-
elated death.8,11 However, it is unknown whether abnormal
lood pressure response is influenced by the HCM-causing
enotype. Here we show that individuals carrying the
92WTNNT2 mutation are 3 times as likely to experience
bnormal blood pressure response upon exercise compared
ith those carrying either of two MYH7 mutations or non-
arrier controls.
We have previously described an increased frequency of
CD, predominantly affecting young males in their teenage
ears, in two ancestrally related families in which the
92WTNNT2 mutation segregates.7 In this study, we report
CDs in a further two of five additional R92WTNNT2 fami-
ies identified (Table 3); these families have been shown by
enetic haplotype analysis (data not shown) to be ances-
rally related to the original two R92WTNNT2 families.7
hile SCD had occurred in four (57%) of the seven
92WTNNT2 families, predominantly affecting young men in
heir teenage years, SCD in MYH7 families was limited to
hose in which the A797TMYH7 mutation segregates (five
50%] of 10 A797TMYH7 families, 39% of total MYH7
amilies) and mostly affected adult individuals (Table 3).
imilar to our first report of the clinical picture associated
ith R92WTNNT2 carriers, overt hypertrophy was a rare
ccurrence in the R92WTNNT2 group7 but occurred more
MYH7 mutation carriers and noncarrier controls
R92WTNNT2 Controls P
379 (266–937) 467 (171–1319) .339
6.5 (3.9–14.7) 6.2 (2.9–12.1) .660
89 (56–104) 94 (75–108) .417
83.7 (24.8–143.1) 89.4 (54.1–118.5) .487
169 (98–211) 170 (123–197) .449
92.0 (28–136) 90.5 (44–137) .499
14 (48) 16 (24) .021
14 (48) 11 (16) .018
0 (0) 5 (8) .357
140 (100–190) 160 (110–220) .064
30 (10–60) 40 (5–100) .020
90 (50–100) 90 (60–120) .589
10 (	10–30) 10 (	20–40) .732
mbers (percentage) for categorical variables. P-values reflect differences
rterial pressure, and resting HR.   change in parameter between resting
redicted maximal HR achieved by peak exercise.
able 4 P-values and estimated odds ratio (OR) for abnormal
lood pressure response in R92WTNNT2 compared with MYH7
arriers and noncarrier control individuals, adjusted for age,
ex, resting mean arterial pressure, resting HR, and family
elatedness
roups OR 95% Confidence interval P
92WTNNT2
MYH7 3.03 1.13, 8.12 .029
92WTNNT2
Control 3.03 1.20, 7.68 .021
YH7NT2 and
4)
2)
)
1.2)
3)
)
0)
)
)
d as nu
mean aControl 1.00 0.42, 2.37 1.000
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S22 Heart Rhythm, Vol 6, No 11S, November Supplement 2009requently in the MYH7 group (n  4, all A797TMYH7
arriers), while syncope occurred at comparable levels in
oth mutation groups (Table 1).
We found that carriers of the R92WTNNT2 mutation dem-
nstrate abnormal blood pressure response to exercise sig-
ificantly more frequently (Tables 2 and 4; P  .021, odds
atio  3.03) and show smaller absolute (SBP, Table 2)
nd relative (% change from resting SBP, Figure 2) changes
n SBP than do carriers of MYH7 mutations or related
oncarrier control individuals. Thus, our study of the largest
umber of cases with an identical mutation in the TNNT2
ene to date provides strong evidence for the influence of
enotype on hemodynamic response in HCM.
In R92WTNNT2 carriers, abnormal blood pressure re-
ponses were always of the flat type, namely, a failure to
ncrease SBP by 20 mmHg between resting and peak
igure 1 Percentage of males and females within each group demon-
trating normal and abnormal blood pressure responses to exercise.
igure 2 Bar graph of adjusted means and 95% confidence interval of
ntransformed values, showing percentage change in hemodynamic pa-sameters from resting to peak exercise. *P  .029.xercise state. This finding, as well as the smaller increases
n SBP observed in this study in the R92WTNNT2 group
uring exercise (Table 2, Figure 1), supports the results of
akata et al,20 who recently reported that a group consisting
f carriers of diverse troponin mutations demonstrated a
maller increase in SBP during exercise than did individuals
ithout troponin mutations.
The mechanisms underlying abnormal blood pressure
esponse to exercise in HCM are not yet completely under-
tood. While some studies indicate that this response is due
o an exaggerated decrease in systemic vascular resis-
ance,9,21 other studies suggest that impaired cardiac output
s responsible for exercise hypotension.22,23 Although it
emains possible that either or a combination of both mech-
nisms are at play in subsets of HCM patients,24 Sakata et
l20 found that systemic vascular resistance decreased to a
imilar extent in the TNNT2 and non-TNNT2 groups. They
roposed that their findings related to the systolic dysfunc-
ion, which would result in decreased cardiac output that
eveloped only in the TNNT2 group during exercise.
The development of abnormal blood pressure response
ay also be related to autonomic control, as studies of
eurotransmitter levels before and after exercise have also
reviously indicated that HCM patients manifest a sympa-
hoadrenal imbalance during exercise.25,26 The cause of this
mbalance is not known, nor is it known whether this im-
alance is genotype related, but it has been suggested that
he enhanced systolic function that occurs under resting
onditions in transgenic mutant TNNT2 mice,27 as well as in
rehypertrophic R92WTNNT2 carriers,13 may activate ven-
ricular mechanoreceptors and cause chronic alterations in
agal tone. On the other hand, Kawasaki et al10 recently
emonstrated that subendocardial ischemia, which occurs in
bout 50% of HCM patients upon exercise,23,28 leads to
agal enhancement in patients with HCM, which may be
elated to the development of abnormal blood pressure re-
igure 3 Mean rate of change in SBP in the groups during early exercise
nd at peak exercise. Values were adjusted for age, sex, body surface area,
esting HR, and resting SBP.ponse to exercise.
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S23Heradien et al Blood Pressure Response to ExerciseThe preponderance of abnormal blood pressure response
n females in the R92WTNNT2 group might be explained by
agal enhancement, which results from either mechanism
roposed above, occurring on the background of the nor-
ally predominantly parasympathetically biased cardiac
egulation in females.29 The preponderance of abnormal
lood pressure response in female R92WTNNT2 carriers, who
xperience less SCD than their male counterparts, could
uggest that this hemodynamic factor is not causally asso-
iated with the high frequency of sudden death with exer-
ise that we have observed in the R92WTNNT2 group. How-
ver, in light of previous longitudinal studies indicating an
ncrease in premature HCM-related death among HCM pa-
ients demonstrating abnormal blood pressure response to
xercise,8,11 the survival and abnormal blood pressure re-
ponse data in this study may suggest that a parasympathetic
hift is not well tolerated in the predominantly sympathet-
cally regulated male hearts.29
Failure to increase SBP appropriately during exercise is
ndicative of severe coronary artery disease in the general
opulation30,31 and is more marked for those who fail to
ncrease SBP appropriately during the first 3 minutes of
xercise rather than later on during exercise.30 This is in-
eresting, given our preliminary observation of the rate of
hange in SBP, which suggests that individuals with the
92WTNNT2 mutation may fail to increase blood pressure ap-
ropriately, particularly early on during exercise (Figure 3).
In contrast to the high rate of abnormal blood pressure
esponse to exercise in the R92WTNNT2 group, the frequency
f abnormal blood pressure response to exercise in the
YH7 group was similar to that reported for genotype-
nknown HCM patients8,9 and was equal to that observed in
he control group of noncarrier relatives (62% from MYH7
nd 38% from R92WTNNT2 families). However, the fre-
uency of abnormal blood pressure response to exercise in
his control group was much higher than that reported for a
on–South African general population (2%–8%).30 The rea-
on for this is not immediately clear; however, half of the
ontrol individuals with abnormal blood pressure response
n this study were overweight or obese (body mass index
25), perhaps indicating a risk for coronary artery disease
nd silent myocardial ischemia.32 Other reported causes of
n abnormal blood pressure response to exercise include
alvular heart disease, orthostatic hypotension, and the use
f drugs such as vasodilators, negative inotropic agents, and
iuretics.30
onclusion
ndividuals with R92WTNNT2 mutations demonstrate abnor-
al blood pressure response to exercise significantly more
requently than do individuals with MYH7 mutations or
oncarrier controls, indicating that abnormal blood pressure
esponse is influenced by genotype. The preponderance of
emale R92WTNNT2 carriers with abnormal blood pressure
esponse, with a lower risk of SCD than affected males,
upports the suggestion that abnormal blood pressure re-
ponse may be associated with a parasympathetic shift inhe regulation of cardiac function and that parasympathetic
hifts are not well tolerated in predominantly sympatheti-
ally regulated male hearts. Although implantable defibril-
ators are the most effective life-saving therapy available for
revention of SCD in HCM, this option is not widely avail-
ble outside of developed nations owing to cost. Elucidating
he molecular mechanisms underlying SCD in HCM may
ventually facilitate development of alternative effective
herapeutic options.
cknowledgment
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ata.
eferences
1. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomy-
opathy in a general population of young adults. Echocardiographic analysis of
4111 subjects in the CARDIA Study. Coronary Artery Risk Development in
(Young) Adults. Circulation 1995;92:785–789.
2. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004;363:1881–
1891.
3. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac
troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl
J Med 1995;332:1058–1064.
4. Varnava AM, Elliott PM, Baboonian C, et al. Hypertrophic cardiomyopathy:
histopathological features of sudden death in cardiac troponin T disease. Circu-
lation 2001;104:1380–1384.
5. Tardiff JC, Hewett TE, Palmer BM, et al. Cardiac troponin T mutations result in
allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
J Clin Invest 1999;104:469–481.
6. Ertz-Berger BR, He H, Dowell C, et al. Changes in the chemical and dynamic
properties of cardiac troponin T cause discrete cardiomyopathies in transgenic
mice. Proc Natl Acad Sci U S A 2005;102:18219–18224.
7. Moolman JC, Corfield VA, Posen B, et al. Sudden death due to troponin T
mutations. J Am Coll Cardiol 1997;29:549–555.
8. Olivotto I, Maron BJ, Montereggi A, et al. Prognostic value of systemic blood
pressure response during exercise in a community-based patient population with
hypertrophic cardiomyopathy. J Am Coll Cardiol 1999;33:2044–2051.
9. Frenneaux MP, Counihan PJ, Caforio AL, et al. Abnormal blood pressure
response during exercise in hypertrophic cardiomyopathy. Circulation 1990;82:
1995–2002.
0. Kawasaki T, Azuma A, Kuribayashi T, et al. Vagal enhancement due to sub-
endocardial ischemia as a cause of abnormal blood pressure response in hyper-
trophic cardiomyopathy. Int J Cardiol 2008;129:59–64.
1. Sadoul N, Prasad K, Elliott PM, et al. Prospective prognostic assessment of
blood pressure response during exercise in patients with hypertrophic cardio-
myopathy. Circulation 1997;96:2987–2991.
2. Moolman-Smook JC, De Lange WJ, Bruwer EC, et al. The origins of hyper-
trophic cardiomyopathy-causing mutations in two South African subpopula-
tions: a unique profile of both independent and founder events. Am J Hum Genet
1999;65:1308–1320.
3. Revera M, Van Der ML, Heradien M, et al. Troponin T and beta-myosin
mutations have distinct cardiac functional effects in hypertrophic cardiomyop-
athy patients without hypertrophy. Cardiovasc Res 2008;77:687–694.
4. Bruce RA, McDonough JR. Stress testing in screening for cardiovascular dis-
ease. Bull N Y Acad Med 1969;45:1288–1305.
5. Nanas S, Nastasiou-Nana M, Dimopoulos S, et al. Early heart rate recovery after
exercise predicts mortality in patients with chronic heart failure. Int J Cardiol
2006;110:393–400.
6. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the
left ventricle by two-dimensional echocardiography. American Society of Echocar-
diography Committee on Standards, Subcommittee on Quantitation of Two-Dimen-
sional Echocardiograms. J Am Soc Echocardiogr 1989;2:358–367.
7. Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract
obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med
2003;348:295–303.
8. Sobel E, Sengul H, Weeks DE. Multipoint estimation of identity-by-descent
probabilities at arbitrary positions among marker loci on general pedigrees. Hum
Hered 2001;52:121–131.
9. Pilia G, Chen WM, Scuteri A, et al. Heritability of cardiovascular and person-
ality traits in 6,148 Sardinians. PLoS Genet 2006;2:e132.
22
2
2
2
2
2
2
2
2
3
3
3
3
S24 Heart Rhythm, Vol 6, No 11S, November Supplement 20090. Sakata K, Ino H, Scuteri N, et al. Exercise-induced systolic dysfunction in
patients with non-obstructive hypertrophic cardiomyopathy and mutations in the
cardiac troponin genes. Heart 2008;94:1282–1287.
1. Counihan PJ, Frenneaux MP, Webb DJ, et al. Abnormal vascular responses to
supine exercise in hypertrophic cardiomyopathy. Circulation 1991;84:686–696.
2. Ciampi Q, Betocchi S, Lombardi R, et al. Hemodynamic determinants of
exercise-induced abnormal blood pressure response in hypertrophic cardiomy-
opathy. J Am Coll Cardiol 2002;40:278–284.
3. Ciampi Q, Betocchi S, Losi MA, et al. Abnormal blood-pressure response to
exercise and oxygen consumption in patients with hypertrophic cardiomyopathy.
J Nucl Cardiol 2007;14:869–875.
4. Lim PO, Morris-Thurgood JA, Frenneaux MP. Vascular mechanisms of sudden
death in hypertrophic cardiomyopathy, including blood pressure responses to
exercise. Cardiol Rev 2002;10:15–23.
5. Omodani H, Kinugawa T, Ogino K, et al. Augmented exercise plasma
noradrenaline with impaired chronotropic responsiveness in patients with
hypertrophic cardiomyopathy. Clin Exp Pharmacol Physiol 1998;25:
1018 –1023.6. Carl I, Ong H, Donnelly R, et al. Exercise in hypertrophic cardiomyopathy is
associated with sympatho-adrenal imbalance. Int J Cardiol 2007;116:124–125.7. Knollmann BC, Blatt SA, Horton K, et al. Inotropic stimulation induces
cardiac dysfunction in transgenic mice expressing a troponin T (I79N)
mutation linked to familial hypertrophic cardiomyopathy. J Biol Chem
2001;276:10039 –10048.
8. Okeie K, Shimizu M, Yoshio H, et al. Left ventricular systolic dysfunction
during exercise and dobutamine stress in patients with hypertrophic cardiomy-
opathy. J Am Coll Cardiol 2000;36:856–863.
9. Kuo TB, Lin T, Yang CC, et al. Effect of aging on gender differences in neural
control of heart rate. Am J Physiol 1999;277:H2233–H2239.
0. Watson G, Mechling E, Ewy GA. Clinical significance of early vs late hypo-
tensive blood pressure response to treadmill exercise. Arch Intern Med 1992;
152:1005–1008.
1. Comess KA, Fenster PE. Clinical implications of the blood pressure response to
exercise. Cardiology 1981;68:233–244.
2. Irace C, Scavelli F, Carallo C, et al. Body mass index, metabolic syndrome and
carotid atherosclerosis. Coron Artery Dis 2009;20:94–99.
3. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for
evaluation of the severity of native valvular regurgitation with two-dimen-
sional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777–
802.
